123 related articles for article (PubMed ID: 3494132)
21. Evaluation of assays to detect immune complexes as an immunodiagnostic aid in patients with melanoma.
Ruell P; Murray E; McCarthy WH; Hersey P
Oncodev Biol Med; 1982; 3(1):1-12. PubMed ID: 6981802
[TBL] [Abstract][Full Text] [Related]
22. Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis.
Araki K; Nagashima H; Tsuji T
Clin Exp Immunol; 1982 Mar; 47(3):520-6. PubMed ID: 6282506
[TBL] [Abstract][Full Text] [Related]
23. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
24. Circulating and tissue-bound immune complexes in allergic vasculitis: relationship between immunoglobulin class and clinical features.
Kauffmann RH; Herrmann WA; Meijer CJ; Daha MR; Vanes LA
Clin Exp Immunol; 1980 Sep; 41(3):459-70. PubMed ID: 7438561
[TBL] [Abstract][Full Text] [Related]
25. The detection of circulating immune complexes in normal subjects using four different methods.
Di Mario U; Guy K; Irvine WJ
J Clin Lab Immunol; 1981 Mar; 5(2):95-9. PubMed ID: 6971334
[TBL] [Abstract][Full Text] [Related]
26. Circulating immune complexes in chronic myeloid leukemia patients at various stages of the disease.
Saranath D; Advani S; Gangal S
Leuk Res; 1983; 7(6):771-7. PubMed ID: 6607388
[TBL] [Abstract][Full Text] [Related]
27. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
[TBL] [Abstract][Full Text] [Related]
28. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
29. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
30. Loss of suppressor T cell function and circulating immune complexes in alcoholic cirrhosis.
Echevarría S; San Miguel G; Rodríguez de Lope C; Castillo E; Pons Romero F
Allergol Immunopathol (Madr); 1985; 13(5):405-10. PubMed ID: 2934964
[TBL] [Abstract][Full Text] [Related]
31. Cell-mediated immune status in patients with squamous cell carcinoma of the oral cavity.
Saranath D; Mukhopadhyaya R; Rao RS; Fakih AR; Naik SL; Gangal SG
Cancer; 1985 Sep; 56(5):1062-70. PubMed ID: 3874683
[TBL] [Abstract][Full Text] [Related]
32. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
Panush RS; Somberg LB; Katz P; Longley S
Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
[TBL] [Abstract][Full Text] [Related]
33. Incidence of circulating immune complexes in patients with acute poststreptococcal glomerulonephritis and in patients with streptococcal impetigo.
Mezzano S; Olavarría F; Ardiles L; López MI
Clin Nephrol; 1986 Aug; 26(2):61-5. PubMed ID: 3530567
[TBL] [Abstract][Full Text] [Related]
34. Circulating immune complexes in breast cancer patients.
Croce MV; Pasqualini RS; Segal-Eiras A
Medicina (B Aires); 1987; 47(4):371-6. PubMed ID: 3502571
[No Abstract] [Full Text] [Related]
35. C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay.
Tappeiner G; Heine KG; Kahl JC; Jordon RE
Clin Exp Immunol; 1977 Apr; 28(1):40-8. PubMed ID: 324678
[TBL] [Abstract][Full Text] [Related]
36. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
[TBL] [Abstract][Full Text] [Related]
37. C1q binding activity in the sera of patients with chronic lung diseases.
Cooper KM; Moore M; Hilton AM
Clin Exp Immunol; 1981 Jul; 45(1):18-28. PubMed ID: 6975678
[TBL] [Abstract][Full Text] [Related]
38. Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.
Ralhan R; Nath N; Agarwal S; Mathur M; Wasylyk B; Shukla NK
Clin Cancer Res; 1998 Sep; 4(9):2147-52. PubMed ID: 9748133
[TBL] [Abstract][Full Text] [Related]
39. C1q microtiter plate ELISA system for detecting circulating immune complexes and its application of testing the sera in neurological diseases.
Araga S; Irie H; Takahashi K
Jpn J Exp Med; 1984 Feb; 54(1):23-7. PubMed ID: 6384588
[TBL] [Abstract][Full Text] [Related]
40. Ferritin levels and circulating immune complexes in patients with solid tumors.
Celada A; Barnet M; Aguado MT; Cruchaud A; Lambert PH
Bull Cancer; 1982; 69(1):22-7. PubMed ID: 6978747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]